600380.SS SHH
Joincare Pharmaceutical Group Industry Co.,Ltd.
1W: +8.3%
1M: +10.3%
3M: +2.9%
YTD: -13.2%
1Y: -17.1%
3Y: -13.9%
5Y: -20.1%
¥10.16 ($1.52)
+0.26 (+2.63%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Balance Sheet Trends
Total Assets
$35.7B
-1.8% ▼
5Y CAGR: +7.0%
Total Liabilities
$12.3B
-10.2% ▼
5Y CAGR: +8.9%
Shareholders Equity
$14.5B
+5.7% ▲
5Y CAGR: +7.0%
Cash & Investments
$14.9B
-7.7% ▼
5Y CAGR: +5.9%
Total Debt
$4.9B
-6.0% ▼
5Y CAGR: +12.8%
Net Debt
-$10.0B
-20.0% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $12.3B | $11.7B | $14.8B | $15.7B | $14.9B |
| Short-Term Investments | $28M | $185M | $109M | $489M | $89M |
| Cash & ST Investments | $12.3B | $11.9B | $14.9B | $16.2B | $14.9B |
| Net Receivables | $4.0B | $4.8B | $5.1B | $4.6B | $4.4B |
| Inventory | $1.8B | $2.1B | $2.6B | $2.7B | $2.6B |
| Other Current Assets | $465M | $541M | $580M | $404M | $770M |
| Total Current Assets | $18.4B | $19.4B | $23.2B | $23.9B | $23.0B |
| Property, Plant & Equip. | $5.0B | $5.6B | $6.1B | $6.5B | $6.3B |
| Goodwill & Intangibles | $1.5B | $1.9B | $1.8B | $1.8B | $1.7B |
| Long-Term Investments | $2.2B | $2.6B | $2.5B | $3.2B | $2.4B |
| Other Non-Current Assets | $579M | $1.1B | $1.5B | $388M | $1.7B |
| Total Non-Current Assets | $9.8B | $11.7B | $12.6B | $12.5B | $12.7B |
| Total Assets | $28.2B | $31.1B | $35.7B | $36.4B | $35.7B |
| — Liabilities — | |||||
| Accounts Payable | $1.9B | $2.5B | $2.6B | $2.4B | $2.2B |
| Short-Term Debt | $2.1B | $2.6B | $2.1B | $2.1B | $2.5B |
| Deferred Revenue | $3.8B | $4.3B | $293M | $0 | $0 |
| Other Current Liabilities | $15M | $3.6B | $458M | $929M | $559M |
| Total Current Liabilities | $7.8B | $9.4B | $9.8B | $9.9B | $9.3B |
| Long-Term Debt | $360M | $827M | $3.2B | $3.1B | $2.4B |
| Other Non-Current Liab. | $546M | $78M | $84M | $460M | $0 |
| Total Non-Current Liabilities | $1.1B | $1.6B | $4.0B | $3.9B | $3.0B |
| Total Liabilities | $8.9B | $10.9B | $13.7B | $13.7B | $12.3B |
| — Equity — | |||||
| Common Stock | $2.0B | $1.9B | $1.9B | $1.9B | $1.9B |
| Retained Earnings | $6.2B | $7.2B | $8.5B | $9.4B | $10.5B |
| Accumulated OCI | $381M | $536M | $861M | $237M | $1.3B |
| Total Stockholders Equity | $11.1B | $11.8B | $13.1B | $13.8B | $14.5B |
| Total Liabilities & Equity | $28.2B | $31.1B | $35.7B | $36.4B | $35.7B |
| — Key Metrics — | |||||
| Total Debt | $2.5B | $3.5B | $5.4B | $5.2B | $4.9B |
| Net Debt | -$9.8B | -$8.3B | -$9.4B | -$8.3B | -$10.0B |
| Total Investments | $2.2B | $2.8B | $2.6B | $3.7B | $2.5B |